Nestin as a marker of cancer stem cells

J Neradil, R Veselska - Cancer science, 2015 - Wiley Online Library
The crucial role of cancer stem cells (CSC s) in the pathology of malignant diseases has
been extensively studied during the last decade. Nestin, a class VI intermediate filament …

Tumor-targeting peptides from combinatorial libraries

R Liu, X Li, W Xiao, KS Lam - Advanced drug delivery reviews, 2017 - Elsevier
Cancer is one of the major and leading causes of death worldwide. Two of the greatest
challenges in fighting cancer are early detection and effective treatments with no or …

Combinatorial peptide libraries: mining for cell-binding peptides

BP Gray, KC Brown - Chemical reviews, 2014 - ACS Publications
The surface of a cell represents a collection of macromolecules, which provides the cell with
a unique cellular landscape specific to the type and state of the cell. Ligands that …

[HTML][HTML] Brain tumor-targeted drug delivery strategies

X Wei, X Chen, M Ying, W Lu - Acta pharmaceutica sinica B, 2014 - Elsevier
Despite the application of aggressive surgery, radiotherapy and chemotherapy in clinics,
brain tumors are still a difficult health challenge due to their fast development and poor …

[HTML][HTML] Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells

Z Zhao, P Lu, H Zhang, H Xu, N Gao, M Li… - Breast Cancer Research, 2014 - Springer
Abstract Introduction We investigated Nestin expression in triple-negative breast cancer and
examined how the modulation of Nestin expression affects cell cycle progression, survival …

Cell surface Nestin is a biomarker for glioma stem cells

X Jin, X Jin, JE Jung, S Beck, H Kim - Biochemical and biophysical …, 2013 - Elsevier
Cancer stem cells (CSCs) are the most aggressive cell type in many malignancies. Cell
surface proteins are generally used to isolate and characterize CSCs. Therefore, the …

[HTML][HTML] Contemporary mouse models in glioma research

WH Hicks, CE Bird, JI Traylor, DD Shi, TY El Ahmadieh… - Cells, 2021 - mdpi.com
Despite advances in understanding of the molecular pathogenesis of glioma, outcomes
remain dismal. Developing successful treatments for glioma requires faithful in vivo disease …

Review on intermediate filaments of the nervous system and their pathological alterations

C Lépinoux-Chambaud, J Eyer - Histochemistry and cell biology, 2013 - Springer
Intermediate filaments (IFs) of the nervous system, including neurofilaments, α-internexin,
glial fibrillary acidic protein, synemin, nestin, peripherin and vimentin, are finely expressed …

Glioblastoma cancer stem cells: Biomarker and therapeutic advances

KB Pointer, PA Clark, M Zorniak, BM Alrfaei… - Neurochemistry …, 2014 - Elsevier
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in
humans. It accounts for fifty-two percent of primary brain malignancies in the United States …

Cancer stem cells, cancer-initiating cells and methods for their detection

S Akbari-Birgani, T Paranjothy, A Zuse, T Janikowski… - Drug discovery today, 2016 - Elsevier
Highlights•Improved early cancer detection, combined with better therapeutic monitoring
procedures and dynamic treatment options, is needed to combat tumor persistence …